Cargando…
Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis
BACKGROUND: Approximately 250,000 heart valve operations are performed annually worldwide. An intensive research and development effort has led to progressively more advanced heart valve prostheses. The Carpentier-Edwards Perimount Magna Ease (CEPME) prosthesis represents the latest iteration of the...
Autores principales: | Rajab, Taufiek K., Ali, Jason M., Hernández-Sánchez, Jules, Mackie, Jennifer, Grimaudo, Vincenzo, Sinichino, Silvia, Mills, Christine, Rana, Bushra, Dunning, John, Abu-Omar, Yasir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397680/ https://www.ncbi.nlm.nih.gov/pubmed/32746882 http://dx.doi.org/10.1186/s13019-020-01248-2 |
Ejemplares similares
-
The Fluid Dynamical Performance of the Carpentier-Edwards PERIMOUNT Magna Ease Prosthesis
por: Marx, Philipp, et al.
Publicado: (2018) -
Eight‐year outcomes of aortic valve replacement with the Carpentier‐Edwards PERIMOUNT Magna Ease valve
por: Tsui, Steven, et al.
Publicado: (2022) -
Early Doppler-echocardiography evaluation of Carpentier-Edwards Standard and Carpentier-Edwards Magna aortic prosthetic valve: comparison of hemodynamic performance
por: Minardi, Giovanni, et al.
Publicado: (2011) -
Early results of the Resilia Inspiris aortic valve in the old age patients - a retrospective comparison with the Carpentier Edwards Magna Ease
por: Shala, Magjun, et al.
Publicado: (2020) -
The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability
por: Loor, Gabriel, et al.
Publicado: (2016)